BKI-1369
Modify Date: 2024-02-04 18:54:00
BKI-1369 structure
|
Common Name | BKI-1369 | ||
|---|---|---|---|---|
| CAS Number | 1951431-22-3 | Molecular Weight | 417.51 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H27N7O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BKI-1369BKI-1369 is a bumped kinase inhibitor (BKI). BKI-1369 increases human Ether-a-go-go-related gene (hERG)-inhibitory activity with an IC50 of 1.52 μM. BKI-1369 reduces the parasite burden and diseases severity in the gnotobiotic pig model. BKI-1369 has been well characterized for potency, stability, metabolism, toxicity, pharmacokinetics and is potent against C. parvum in infected mice and calves[1]. |
| Name | BKI-1369 |
|---|
| Description | BKI-1369 is a bumped kinase inhibitor (BKI). BKI-1369 increases human Ether-a-go-go-related gene (hERG)-inhibitory activity with an IC50 of 1.52 μM. BKI-1369 reduces the parasite burden and diseases severity in the gnotobiotic pig model. BKI-1369 has been well characterized for potency, stability, metabolism, toxicity, pharmacokinetics and is potent against C. parvum in infected mice and calves[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1.52 μM (hERG)[1] |
| References |
| Molecular Formula | C23H27N7O |
|---|---|
| Molecular Weight | 417.51 |